Abnormalities of circulating 25-OH vitamin D after jejunal-lleal bypass for obesity: evidence of an adaptive response
- PMID: 842987
- DOI: 10.7326/0003-4819-86-3-289
Abnormalities of circulating 25-OH vitamin D after jejunal-lleal bypass for obesity: evidence of an adaptive response
Abstract
Circulating levels of 25-OH vitamin D were measured in 44 patients who had undergone small intestinal bypass for obesity. Sixty-one percent had low circulating levels of the metabolite, which tended to normalize with time. This adaptive response also occurred for circulating total calcium, magnesium, albumin, and alkaline phosphatase. Serum concentrations of 25-OH vitamin D were directly related to total serum calcium and albumin. Impaired intestinal absorption of 25-OH vitamin D was seen in two patients. Following correction of total serum calcium for attendant hypoalbuminemia, 27% of patients remained hypocalcemic. The bone densities of two of 32 patients were low. In addition, skeletal biopsies of three of six patients were abnormal. It is concluded that small intestinal bypass results in at least transient deficits of circulating 25-OH vitamin D. As this operation may be associated with abnormal bone morphology, clinically significant skeletal disease may become apparent with long-term follow-up.
Similar articles
-
Skeletal abnormalities after jejunoileal bypass.Ann Surg. 1979 Jun;189(6):785-90. doi: 10.1097/00000658-197906000-00016. Ann Surg. 1979. PMID: 453949 Free PMC article.
-
Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity.Gut. 1980 Jul;21(7):624-31. doi: 10.1136/gut.21.7.624. Gut. 1980. PMID: 7429327 Free PMC article.
-
Impairment of vitamin D metabolism and bone mineral content after intestinal bypass for obesity. A longitudinal study.Scand J Gastroenterol. 1984 Mar;19(2):184-9. Scand J Gastroenterol. 1984. PMID: 6609420
-
Bone disease after jejuno-ileal bypass for obesity.Lancet. 1978 Jul 1;2(8079):1-4. doi: 10.1016/s0140-6736(78)91318-1. Lancet. 1978. PMID: 78209
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
Changes in plasma half-life and clearance of 3H-25-hydroxyvitamin D3 in patients with intestinal malabsorption.Gut. 1982 Dec;23(12):1068-71. doi: 10.1136/gut.23.12.1068. Gut. 1982. PMID: 7173717 Free PMC article.
-
Evidence for alteration of the vitamin D-endocrine system in obese subjects.J Clin Invest. 1985 Jul;76(1):370-3. doi: 10.1172/JCI111971. J Clin Invest. 1985. PMID: 2991340 Free PMC article.
-
Skeletal abnormalities after jejunoileal bypass.Ann Surg. 1979 Jun;189(6):785-90. doi: 10.1097/00000658-197906000-00016. Ann Surg. 1979. PMID: 453949 Free PMC article.
-
Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity.Gut. 1980 Jul;21(7):624-31. doi: 10.1136/gut.21.7.624. Gut. 1980. PMID: 7429327 Free PMC article.
-
Evidence for alteration of the vitamin D-endocrine system in blacks.J Clin Invest. 1985 Aug;76(2):470-3. doi: 10.1172/JCI111995. J Clin Invest. 1985. PMID: 3839801 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials